Gene: ZNF333
Official Full Name: zinc finger protein 333provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24869 | ZNF333 Knockout cell line (HeLa) | Human | ZNF333 | 1:3~1:6 | Negative | Online Inquiry |
KO24870 | ZNF333 Knockout cell line (HCT 116) | Human | ZNF333 | 1:2~1:4 | Negative | Online Inquiry |
KO24871 | ZNF333 Knockout cell line (HEK293) | Human | ZNF333 | 1:3~1:6 | Negative | Online Inquiry |
KO24872 | ZNF333 Knockout cell line (A549) | Human | ZNF333 | 1:3~1:4 | Negative | Online Inquiry |
ZNF333 Gene Knockout Cell Lines represent a groundbreaking product designed for the precise study of gene function and regulation. These cell lines are genetically modified to have the ZNF333 gene inactivated, allowing researchers to elucidate its role in cellular processes, including transcriptional regulation, cell differentiation, and response to stressors. By employing CRISPR-Cas9 technology, the knockout of the ZNF333 gene generates a null phenotype, serving as an invaluable tool for investigating the gene's biological significance.
The key mechanisms working within these knockout cell lines include the disruption of ZNF333-associated signaling pathways and gene expression profiles, enabling researchers to track and analyze downstream effects. This detailed insight into gene function plays a vital role in enhancing our understanding of various diseases, particularly those with epigenetic components. In clinical settings, ZNF333's involvement in tumorigenesis or other pathological conditions can be explored, offering potential avenues for therapeutic interventions.
Compared to conventional gene editing methods, ZNF333 Gene Knockout Cell Lines provide several unique advantages. They offer robust reproducibility in experimental setups, reduced off-target effects, and the ability to study phenotypic changes in real-time. Additionally, these cell lines can be adapted for high-throughput screening, making them a valuable asset for drug discovery and development efforts.
For researchers and clinicians alike, utilizing ZNF333 Gene Knockout Cell Lines fosters deeper insights into genetic mechanisms underpinning health and disease, accelerating advancements in genomic research and clinical applications. Their ability to provide reliable and reproducible data underpins their irreplaceable role in contemporary biological research.
At [Your Company Name], we are dedicated to delivering precision biological products that enhance experimental outcomes and empower scientific discovery. Our expertise in gene editing technologies and commitment to quality ensures that our users have access to cutting-edge tools for advancing their research missions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.